Case number 1:25-cv-00719
Bayer Pharma AG et al v. Macleods Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 28, 2025 | 27 | SO ORDERED Granting Stipulation and Order Regarding Stay (D.I. 26 in 25-cv-719-RGA; D.I. 184 in 21-cv-314-RGA-LDH; D.I. 381 in 21-md-3017-RGA-LDH). Signed by Judge Richard G. Andrews on 10/28/2025. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:25-cv-00719-RGA(nms) (Entered: 10/28/2025) (2) |
| Oct 27, 2025 | 26 | STIPULATION and [Proposed] Order Regarding Stay - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/28/2025 (nms). (Entered: 10/27/2025) (2) |
| Sep 30, 2025 | 25 | REDACTED VERSION of 18 Unopposed Motion for Leave to File to File Answer and Counterclaims Under Seal by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Stamoulis, Stamatios) (Entered: 09/30/2025) (0) |
| Sep 30, 2025 | N/A | SO ORDERED, re 23 MOTION for Pro Hac Vice Appearance of Attorney Corey Weinstein, Neal Seth and Wesley E. Weeks filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc.. Signed by Judge Richard G. Andrews on 9/30/2025. (aas) (Entered: 09/30/2025) (0) |
| Sep 30, 2025 | 24 | Pro Hac Vice Fee - Credit Card Payment received for Corey Weinstein, Neal Seth, and Wesley E. Weeks. ( re 23 MOTION for Pro Hac Vice Appearance of Attorney Corey Weinstein, Neal Seth and Wesley E. Weeks )( Payment of $ 150, receipt number ADEDC-4801810).(Stamoulis, Stamatios) (Entered: 09/30/2025) (0) |
| Sep 30, 2025 | 23 | MOTION for Pro Hac Vice Appearance of Attorney Corey Weinstein, Neal Seth and Wesley E. Weeks - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Stamoulis, Stamatios) (Entered: 09/30/2025) (7) |
| Sep 26, 2025 | 22 | REDACTED VERSION of 20 Answer to Complaint, Counterclaim by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Stamoulis, Stamatios) (Entered: 09/26/2025) (27) |
| Sep 26, 2025 | N/A | SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 18 . (nms) (Entered: 09/26/2025) (0) |
| Sep 22, 2025 | N/A | REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 18 . (nms) (Entered: 09/22/2025) (0) |
| Sep 19, 2025 | N/A | SO ORDERED, re 21 STIPULATION to Extend Time to Respond to Counterclaims (*Reset Answer Deadlines: Bayer AG answer due 11/3/2025; Bayer Pharma AG answer due 11/3/2025; Janssen Pharmaceuticals, Inc. answer due 11/3/2025). Signed by Judge Richard G. Andrews on 9/19/2025. (nms) (Entered: 09/19/2025) (0) |
| Sep 19, 2025 | 21 | STIPULATION to Extend Time to Respond to Counterclaims - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/19/2025 (nms). (Entered: 09/19/2025) (2) |
| Sep 15, 2025 | 20 | [SEALED] ANSWER to 3 Complaint, , COUNTERCLAIM against All Parties by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Stamoulis, Stamatios) (Entered: 09/15/2025) (0) |
| Sep 11, 2025 | 19 | ORAL ORDER: The Unopposed Motion for Leave to File Answer and Counterclaims Under Seal (D.I. 18 in 25-cv-719-RGA; D.I. 360 in 21-md-3017-RGA-LDH) is GRANTED. Ordered by Judge Richard G. Andrews on 9/11/2025. Associated Cases: 1:25-cv-00719-RGA, 1:21-md-03017-RGA-LDH(nms) (Entered: 09/11/2025) (0) |
| Sep 10, 2025 | 18 | [SEALED] Unopposed Motion for Leave to File to File Answer and Counterclaims Under Seal - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Stamoulis, Stamatios) Modified on 9/10/2025 (nms). Modified on 9/11/2025 (nms). (Entered: 09/10/2025) (0) |
| Sep 8, 2025 | N/A | CORRECTING ENTRY: The answer filed on 9/5/2025 at D.I. 18 and the disclosure statement filed that same day at D.I. 19 have been removed from the docket. This case is part of MDL 21-3017-RGA and therefore requires that all filings be captioned for the MDL and the underlying member case(s). Further, it was noted that the answer was filed under seal but no application authorizing its sealing was presented in advance of the filing. Counsel for Defendants is to resubmit accordingly. (nms) (Entered: 09/08/2025) (0) |
| Sep 3, 2025 | 17 | NOTICE requesting Clerk to remove Gwen Hochman Stewart as co-counsel. Reason for request: no longer associated with the case. (Fahnestock, Derek) (Entered: 09/03/2025) (9) |
| Sep 3, 2025 | N/A | SO ORDERED, re 15 MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 9/3/2025. (aas) (Entered: 09/03/2025) (0) |
| Sep 3, 2025 | 16 | Pro Hac Vice Fee - Credit Card Payment received for Stephanie P. Koh. ( re 15 MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh )( Payment of $ 50, receipt number ADEDC-4780509).(Fahnestock, Derek) (Entered: 09/03/2025) (0) |
| Sep 3, 2025 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh - filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/03/2025) (11) |
| Aug 8, 2025 | N/A | SO ORDERED, re 14 Joint Stipulation to Extend Time to Answer (*Reset Answer Deadlines: Macleods Pharma USA, Inc. answer due 9/8/2025; Macleods Pharmaceuticals Ltd. answer due 9/8/2025). Signed by Judge Richard G. Andrews on 8/8/2025. (nms) (Entered: 08/08/2025) (0) |
| Aug 7, 2025 | 14 | Joint Stipulation to Extend Time to answer, move, or otherwise respond to the Complaint to September 8, 2025 - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Stamoulis, Stamatios) Modified on 8/8/2025 (nms). (Entered: 08/07/2025) (2) |
| Jul 2, 2025 | N/A | SO ORDERED, re 13 Unopposed Motion to Extend Time (*Reset Answer Deadlines: Macleods Pharma USA, Inc. answer due 8/8/2025; Macleods Pharmaceuticals Ltd. answer due 8/8/2025). Signed by Judge Richard G. Andrews on 7/2/2025. (nms) (Entered: 07/02/2025) (0) |
| Jul 2, 2025 | 13 | Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/2/2025 (nms). (Entered: 07/02/2025) (2) |
| Jul 2, 2025 | 12 | SUMMONS Returned Executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc..Macleods Pharma USA, Inc. served on 7/1/2025, answer due 7/22/2025. (Fahnestock, Derek) (Entered: 07/02/2025) (2) |
| Jul 2, 2025 | 11 | SUMMONS Returned Executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc..Macleods Pharmaceuticals Ltd. served on 7/1/2025, answer due 7/22/2025. (Fahnestock, Derek) (Entered: 07/02/2025) (2) |
| Jun 16, 2025 | 10 | REDACTED VERSION of 3 Complaint, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(Fahnestock, Derek) Modified on 6/16/2025 (nms). (Entered: 06/16/2025) (0) |
| Jun 11, 2025 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:25-cv-00719-UNA, 1:25-cv-00694-UNA (alb) (Entered: 06/11/2025) (0) |
| Jun 9, 2025 | 9 | ORDER Granting 1 Motion for Leave to File Complaint Under Seal. A redacted version of the complaint shall be filed within seven days. Signed by Judge Richard G. Andrews on 6/9/2025. (aas) (Entered: 06/09/2025) (1) |
| Jun 9, 2025 | N/A | CORRECTING ENTRY: The docket text for D.I. 5 has been amended. The patent number has been corrected. The NEF for D.I. 5 has been regenerated. (nms) (Entered: 06/09/2025) (0) |
| Jun 9, 2025 | N/A | Remark: Exit electronic copies to Judge, RGA (mrr) (Entered: 06/09/2025) (0) |
| Jun 9, 2025 | N/A | Remark: The MDL Panel has been notified of case 1:25-cv-00719-UNA which relates with 1:21-md-03017-RGA-LDH (mrr) (Entered: 06/09/2025) (0) |
| Jun 9, 2025 | 8 | Summons Issued as to Macleods Pharma USA, Inc. on 6/9/2025; Macleods Pharmaceuticals Ltd. on 6/9/2025. (Attachments: # 1 Summons Issued)(mrr) (Entered: 06/09/2025) (0) |
| Jun 9, 2025 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025) (1) |
| Jun 9, 2025 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025) (1) |
| Jun 9, 2025 | 5 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US, 10,828,310. (mrr) (Entered: 06/09/2025) (1) |
| Jun 9, 2025 | 4 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 06/09/2025) (3) |
| Jun 9, 2025 | 3 | [SEALED] COMPLAINT with Jury Demand against Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. (Filing fee $ 405, receipt number ADEDC-4706261) - filed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(mrr) (Entered: 06/09/2025) (0) |
| Jun 9, 2025 | 2 | DECLARATION of David Schramm re 1 MOTION for Leave to File Complaint Under Seal by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/09/2025) (2) |
| Jun 9, 2025 | 1 | MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Proposed Order)(mrr) (Entered: 06/09/2025) (0) |
